Original InvestigationBenefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction
Key Words
Abbreviations and Acronyms
Cited by (0)
This research is sponsored by the Harvard Clinical Research Institute and funded by Abbott, Boston Scientific Corporation, Cordis Corporation, Medtronic, Inc., Bristol-Myers Squibb Company/Sanofi Pharmaceuticals Partnership, Eli Lilly and Company, and Daiichi-Sankyo Company Limited, and the U.S. Department of Health and Human Services (1RO1FD003870-01). Dr. Yeh is on the advisory board of Abbott Vascular; and has received consulting fees from Gilead Sciences and Merck. Dr. Kereiakes has served as a consultant for Boston Scientific and Abbott Vascular. Dr. Steg has received personal fees from Amarin, AstraZeneca, Bayer, Boehringer-Ingelheim, Bristol-Myers Squibb, Daiichi-Sankyo, GlaxoSmithKline, Eli Lilly, Merck-Sharpe-Dohme, Novartis, Otsuka, Pfizer, Roche, Medtronic, Sanofi, Servier, Vivus, Janssen, The Medicines Company, and Orexigen; and has received grants from Sanofi and Servier. Dr. Windecker has received research grants to the institution from Abbott, Biotronik, Boston Scientific, Edwards Lifesciences, Medtronic, The Medicines Company, and St. Jude; and speaker fees from AstraZeneca, Eli Lilly, Abbott, Biotronik, Boston Scientific, Bayer, and Biosensors. Dr. Gershlick has received personal fees from Medtronic and Abbott; and grants from The Medicines Company. Dr. Cutlip has received other fees from Medtronic, Boston Scientific, Cordis Inc., and Abbott Vascular; and grants from the National Heart, Lung, and Blood Institute during the conduct of the study. Dr. Cohen has received research grant support to the institution from Eli Lilly, AstraZeneca, Daiichi-Sankyo, Abbott Vascular, Boston Scientific, and Medtronic; and consulting fees from Eli Lilly, AstraZeneca, Abbott Vascular, and Medtronic. Dr. Tanguay has received personal fees and other from Abbott Vascular, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, and Sanofi; personal fees from Bayer, Roche, and Servier; and other fees from Ikaria and Merck. Dr. Wiviott has received grants and personal fees from AstraZeneca, Bristol-Myers Squibb, Arena, and Eli Lilly/Daiichi-Sankyo; grants from Eisai, Merck, and Sanofi; and personal fees from Aegerion, Angelmed, Janssen, Xoma, ICON Clinical, and the Boston Clinical Research Institute. Dr. Massaro has received personal fees from the Harvard Clinical Research Institute during the conduct of the study. Dr. Mauri has received institutional research grants from Abbott, Boston Scientific, Cordis, Medtronic, Eli Lilly/Daiichi-Sankyo, and Sanofi/Bristol-Myers Squibb; and personal fees from Medtronic, Recor, St. Jude Medical, and Biotronik. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
P. K. Shah, MD, served as Guest Editor for this paper.